Metrikler
Yayın
2
Açık Erişim
1
Makaleler
Tümü (1)
SCI-E, SSCI, AHCI (1)
SCI-E, SSCI, AHCI, ESCI (1)
Scopus (1)
2022
20221. Correspondence on 'Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial'
SATIŞ H., AYDEMİR E., İZMİRLİOĞLU K., TUFAN A.
Annals of the rheumatic diseases
, cilt.81, sa.12, 2022 (SCI-Expanded, Scopus)
